Y116N (p.Tyr116Asn) variant of ABL2 (Tyrosine-protein kinase ABL2)
Y116N (p.Tyr116Asn) in ABL2 (Tyrosine-protein kinase ABL2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact.
Y116N (p.Tyr116Asn) variant details
- p.Tyr116Asn
- NCI-TCGA TCGA novel
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.